THMO — Thermogenesis Holdings Share Price
0.000.00%
Last trade - 00:00- $2.22m
- $3.19m
- $9.45m
- 20
- 47
- 29
- 23
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 1.71 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.92 | ||
| Price to Tang. Book | 1.92 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.19 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -460.4% | ||
| Return on Equity | -417.94% | ||
| Operating Margin | -85.42% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 13.05 | 9.74 | 9.29 | 10.48 | 9.45 | 16.9 | 21.11 | -0.47% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +150 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
ThermoGenesis Holdings, Inc. develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. The Company provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, the PXP platform for point-of-care cell-based therapies and X-Series products for cell processing services. Its product lines include Clinical Bio-Banking Applications, Point-of-Care Applications and Cell Processing. Its Clinical Bio-Banking Applications include AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, and PXP-1000 System. Its Cell Processing includes X-Series Products for general laboratory use: X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The Company markets and sells its medical device products through independent distributors.
Directors
- Xiaochun Xu CHM (50)
- Jeffery Cauble CFO (48)
- Debra Donaghy IND (64)
- Russell Medford IND (66)
- Joseph Thomis IND (75)
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- July 3rd, 1986
- Public Since
- June 5th, 1987
- No. of Shareholders
- 141
- No. of Employees
- 25
- Sector
- Office Equipment
- Industry
- Technology
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 7,952,780
- Address
- 2711 Citrus Rd, RANCHO CORDOVA, 95742-6228
- Web
- https://thermogenesis.com
- Phone
- +1 9168585100
- Auditors
- Marcum LLP
Upcoming Events for THMO
Q3 2024 Thermogenesis Holdings Inc Earnings Release
Thermogenesis Holdings Inc Annual Shareholders Meeting
Similar to THMO
Canon
Pink Sheets on Nasdaq
Dynasil of America
Pink Sheets on Nasdaq
Electro Optical Systems
Pink Sheets on Nasdaq
Global Payment Technologies
Pink Sheets on Nasdaq
IncJet Holding
Pink Sheets on Nasdaq
FAQ
What is the Thermogenesis Holdings share price?
As of Today at 11:44 UTC, shares in Thermogenesis Holdings are trading at $0.24. This share price information is delayed by 15 minutes.
How has the Thermogenesis Holdings share price performed this year?
Shares in Thermogenesis Holdings last closed at $0.24 and the price had moved by -82.19% over the past 365 days. In terms of relative price strength the Thermogenesis Holdings share price has underperformed the S&P500 Index by -85.05% over the past year.
What are the analyst and broker recommendations for Thermogenesis Holdings?
The overall consensus recommendation for Thermogenesis Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Thermogenesis Holdings dividend yield?
Thermogenesis Holdings does not currently pay a dividend.
Does Thermogenesis Holdings pay a dividend?
Thermogenesis Holdings does not currently pay a dividend.
When does Thermogenesis Holdings next pay dividends?
Thermogenesis Holdings does not currently pay a dividend.
How do I buy Thermogenesis Holdings shares?
To buy shares in Thermogenesis Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Thermogenesis Holdings?
As of the previous close price of $0.24, shares in Thermogenesis Holdings had a market capitalisation of $1.87m.
Where are Thermogenesis Holdings shares listed?
Here are the trading details for Thermogenesis Holdings:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: THMO
What kind of share is Thermogenesis Holdings?
Based on an overall assessment of its quality, value and momentum Thermogenesis Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Thermogenesis Holdings share price forecast for 2024?
The analyst consensus target price for shares in Thermogenesis Holdings is $5.00. That is 2026.75% above the last closing price of $0.24.
Analysts covering Thermogenesis Holdings currently have a consensus Earnings Per Share (EPS) forecast of $0.08 for the next financial year.
What is the trend in the Thermogenesis Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Thermogenesis Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -65.66%.
As of the last closing price of $0.24, shares in Thermogenesis Holdings were trading -70.76% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Thermogenesis Holdings PE Ratio?
The Thermogenesis Holdings PE ratio based on its reported earnings over the past 12 months is 1.71. The shares last closed at $0.24.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Thermogenesis Holdings?
Thermogenesis Holdings' management team is headed by:
- Xiaochun Xu - CHM
- Jeffery Cauble - CFO
- Debra Donaghy - IND
- Russell Medford - IND
- Joseph Thomis - IND